ABI3 | ABI family, member 3 | | | | | | Tissue enhanced |
AC004017.1 | Uncharacterized protein | | | | | | Tissue enhanced |
AC007952.5 | Uncharacterized protein ENSP00000382042 | | | | | | Tissue enhanced |
AC007952.6 | Uncharacterized protein | | | | | | Tissue enhanced |
AC103801.2 | | | | | | | Tissue enhanced |
ADRA1B | Adrenoceptor alpha 1B | Cancer-related genes FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
AIF1L | Allograft inflammatory factor 1-like | | | | | | Tissue enhanced |
APLNR | Apelin receptor | G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
C10orf105 | Chromosome 10 open reading frame 105 | | | | | | Tissue enhanced |
C19orf35 | Chromosome 19 open reading frame 35 | | | | | | Tissue enhanced |
C1QTNF1-AS1 | C1QTNF1 antisense RNA 1 | | | | | | Tissue enhanced |
C21orf90 | Chromosome 21 open reading frame 90 | | | | | | Tissue enhanced |
C5AR2 | Complement component 5a receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
C9orf139 | Chromosome 9 open reading frame 139 | | | | | | Tissue enhanced |
CABP4 | Calcium binding protein 4 | Disease related genes
| | | | | Tissue enhanced |
CCL14 | Chemokine (C-C motif) ligand 14 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD160 | CD160 molecule | CD markers Predicted secreted proteins
| | | | | Tissue enhanced |
CD226 | CD226 molecule | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD244 | CD244 molecule, natural killer cell receptor 2B4 | CD markers Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CD300LF | CD300 molecule-like family member f | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD7 | CD7 molecule | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD79B | CD79b molecule, immunoglobulin-associated beta | Cancer-related genes CD markers Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
CD8A | CD8a molecule | CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CDH4 | Cadherin 4, type 1, R-cadherin (retinal) | Predicted membrane proteins
| | | | | Tissue enhanced |
CETP | Cholesteryl ester transfer protein, plasma | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CFP | Complement factor properdin | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CHRM4 | Cholinergic receptor, muscarinic 4 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CPLX3 | Complexin 3 | | | | | | Tissue enhanced |
CRABP1 | Cellular retinoic acid binding protein 1 | Cancer-related genes Plasma proteins
| | | | | Tissue enhanced |
CRHBP | Corticotropin releasing hormone binding protein | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CTD-2215E18.1 | Uncharacterized protein | | | | | | Tissue enhanced |
CXCL1 | Chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CXCL6 | Chemokine (C-X-C motif) ligand 6 | Predicted secreted proteins
| | | | | Tissue enhanced |
CXCR1 | Chemokine (C-X-C motif) receptor 1 | Cancer-related genes CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
DNASE1L3 | Deoxyribonuclease I-like 3 | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
DPEP2 | Dipeptidase 2 | Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
EMR1 | Egf-like module containing, mucin-like, hormone receptor-like 1 | G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
EOMES | Eomesodermin | Disease related genes Transcription factors
| | | | | Tissue enhanced |
EPHA8 | EPH receptor A8 | Cancer-related genes Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
EXOC3L1 | Exocyst complex component 3-like 1 | | | | | | Tissue enhanced |
FAIM3 | Fas apoptotic inhibitory molecule 3 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FAM26F | Family with sequence similarity 26, member F | Predicted membrane proteins
| | | | | Tissue enhanced |
FCGR3A | Fc fragment of IgG, low affinity IIIa, receptor (CD16a) | CD markers FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FCGR3B | Fc fragment of IgG, low affinity IIIb, receptor (CD16b) | CD markers FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
FCRL1 | Fc receptor-like 1 | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FCRL6 | Fc receptor-like 6 | Predicted membrane proteins
| | | | | Tissue enhanced |
FGD2 | FYVE, RhoGEF and PH domain containing 2 | Cytoskeleton related proteins
| | | | | Tissue enhanced |
FLJ00418 | | | | | | | Tissue enhanced |
FRZB | Frizzled-related protein | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
FUT7 | Fucosyltransferase 7 (alpha (1,3) fucosyltransferase) | | | | | | Tissue enhanced |